Pfizer to create up to 500 jobs in Dublin with €1.2 billion investment

Pharma giant Pfizer recently revealed plans to invest €1.2 billion and build a new facility in Dublin, adding hundreds of jobs in the process.

The capacity for the production of biological drug substances will be doubled by the new facility, which will be constructed on the site at Grange Castle in west Dublin.

Between 400 and 500 new permanent jobs will be created as a result of the investment, which will be the single-largest investment made by Pfizer in Ireland to date.

Pfizer currently employs around 5,000 people in Ireland.

The announcement has been welcomed by BioPharmaChem Ireland (BPCI), the Ibec group that represents the biopharma and chemical industry in Ireland.

The industry, according to its director Matt Moran, exports goods worth more than €100 billion annually, directly employs over 42,000 people, and is responsible for another 42,000 people indirectly.

“To underpin the sector’s continued growth and capacity to compete internationally for resources and talent, it is imperative that the industry continues to invest in these kind of advanced manufacturing projects. It is great to see Pfizer endorse the Irish business model, and BPCI and the wider industry warmly welcome this investment,” Moran added.

Speaking about the investment Tánaiste Leo Varadkar said: ‘’The pharma sector is such an important part of the Irish economy and the commitment shown by Pfizer to further expand its business here is great news.

“The work undertaken at their facilities across Ireland saves and improves the lives of people all over the world.  I am very pleased that their presence in Dublin, and indeed in Ireland, continues to go from strength to strength.’’

IDA Ireland Interim CEO Mary Buckley said: ‘’Pfizer has had a presence in Ireland for over 50 years and this major additional investment, adding further drug substance capacity to its already substantial Irish operations and jobs, underscores the strategic importance of Ireland in Pfizer’s global operations. It is proof of the company’s future commitment to Ireland and testament to Ireland’s continued attractiveness as a location for investment.’’

%d bloggers like this: